Upon completion of the first year of its research program on Drug Regulatory Reforms in India, ICRIER organized a dissemination seminar on September 25, 2015 at India Habitat Centre, New Delhi. The seminar brought together a number of experts including those from the government, industry, international organizations, academia and even the civil society.

The inaugural session of the program was addressed by three distinguished speakers, beginning with Dr G N Singh, Drugs Controller General of India, Central Drugs Standard Control Organization. This was followed by a special address by the eminent medical researcher, Prof Ranjit Roy Chaudhury who spoke of several issues of critical importance in this sector such as regulation of clinical trials, the anomaly of having two ministries, quality of drugs and the centre-state relationship. The session concluded with a keynote address by Dr Kathleen Holloway, Regional Advisor in Essential Drugs and Other Medicines at WHO/SEARO. The presentation and discussion session was chaired by Dr Aditya Bhattacharjea, Professor and Head, Department of Economics, Delhi School of Economics, and eminent panelists included Dr Hemant Koshia, Commissioner, FDA Gujarat; Shri Ravi Prakash Gupta, Controller, FDA Chattisgarh; Ms Susan Winckler, Managing Partner, Leavitt Partners, Washington DC; Mr Richard Kingham, Partner, Covington and Burling, Washington DC and Mr D G Shah, Secretary General, Indian Pharmaceutical Alliance, Mumbai. The research papers Administrative Structure and Functions of Drug Regulatory Authorities in India and Drug Quality and Safety Issues in India, were presented by Dr Nupur Chowdhury and MrMaulikChokshi respectively.